Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmine Lim

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
World Journal of Urology|March 3, 2025
Primary management of prostate cancer by universal health coverage effective coverage indexLeandro Blas, Masaki Shiota, Mizuki Onozawa, et al.
European Journal of Epidemiology|July 18, 2021
Marital status and prostate cancer incidence: a pooled analysis of 12 case-control studies from the PRACTICAL consortiumCharlotte Salmon, Lixin Song, Kenneth Muir, et al.
BJU International|May 12, 2019
Management of advanced prostate cancer in a middle-income country: real-world consideration of the Advanced Prostate Cancer Consensus Conference 2017Marniza Saad, Adlinda Alip, Jasmine Lim, et al.
Prostate International|August 23, 2017
Report of the Second Asian Prostate Cancer (A-CaP) Study MeetingChoung-Soo Kim, Ji Youl Lee, Byung Ha Chung, et al.
JHEP Reports : Innovation in Hepatology|May 11, 2023
A genomic enhancer signature associates with hepatocellular carcinoma prognosisAh-Jung Jeon, Chukwuemeka George Anene-Nzelu, Yue-Yang Teo, et al.
BMC Cancer|February 4, 2023
Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular CarcinomaAh-Jung Jeon, Yue-Yang Teo, Karthik Sekar, et al.
Journal of Hepatology|May 23, 2024
A multimodal atlas of hepatocellular carcinoma reveals convergent evolutionary paths and 'bad apple' effect on clinical trajectoryJianbin Chen, Neslihan Arife Kaya, Ying Zhang, et al.
Nature Cancer|January 26, 2026
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS studyJason L Vassy, Anna M Dornisch, Roshan Karunamuni, et al.
Nature Communications|June 13, 2018
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variantsTokhir Dadaev, Edward J Saunders, Paul J Newcombe, et al.
Nature Genetics|January 10, 2019
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociFredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
World Journal of Urology|March 3, 2025
Primary management of prostate cancer by universal health coverage effective coverage indexLeandro Blas, Masaki Shiota, Mizuki Onozawa, et al.
European Journal of Epidemiology|July 18, 2021
Marital status and prostate cancer incidence: a pooled analysis of 12 case-control studies from the PRACTICAL consortiumCharlotte Salmon, Lixin Song, Kenneth Muir, et al.
BJU International|May 12, 2019
Management of advanced prostate cancer in a middle-income country: real-world consideration of the Advanced Prostate Cancer Consensus Conference 2017Marniza Saad, Adlinda Alip, Jasmine Lim, et al.
Prostate International|August 23, 2017
Report of the Second Asian Prostate Cancer (A-CaP) Study MeetingChoung-Soo Kim, Ji Youl Lee, Byung Ha Chung, et al.
JHEP Reports : Innovation in Hepatology|May 11, 2023
A genomic enhancer signature associates with hepatocellular carcinoma prognosisAh-Jung Jeon, Chukwuemeka George Anene-Nzelu, Yue-Yang Teo, et al.
BMC Cancer|February 4, 2023
Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular CarcinomaAh-Jung Jeon, Yue-Yang Teo, Karthik Sekar, et al.
Journal of Hepatology|May 23, 2024
A multimodal atlas of hepatocellular carcinoma reveals convergent evolutionary paths and 'bad apple' effect on clinical trajectoryJianbin Chen, Neslihan Arife Kaya, Ying Zhang, et al.
Nature Cancer|January 26, 2026
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS studyJason L Vassy, Anna M Dornisch, Roshan Karunamuni, et al.
Nature Communications|June 13, 2018
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variantsTokhir Dadaev, Edward J Saunders, Paul J Newcombe, et al.
Nature Genetics|January 10, 2019
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociFredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, et al.
Pageof 5